Verus Capital Partners »

AstraZeneca shares owned by Verus Capital Partners

Quarter-by-quarter ownership of AstraZeneca shares owned by Verus Capital Partners from 13F filings

Historical chart of Verus Capital Partners investment in AstraZeneca

Tip: Access up to 7 years of quarterly data

All positions including AstraZeneca held by Verus Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in AstraZeneca by Verus Capital Partners

Quarter filed Position value Share count Share price at filing
2025-12-31 $202k 2.2k 91.91
2020-03-31 $25k 550 45.45
2019-12-31 $27k 550 49.09

More positions owned by Verus Capital Partners

Apple (AAPL)
NVIDIA Corporation Call Option (NVDA)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Advanced Micro Devices (AMD)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Series Trust State Street Spd (SPYG)
Ishares Tr Core S&p500 Etf (IVV)
Guggenheim Strategic Opportu Com Sbi (GOF)
Spdr Series Trust State Street Spd (SPYM)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Palantir Technologies Cl A (PLTR)

View all positions for Verus Capital Partners

Top funds holding AstraZeneca

PRIMECAP Management Company
Wellington Management Company
FMR
Fisher Investments
Franklin Resources
Capital Research and Management Company - Division 3
Goldman Sachs Group
Sanders Capital
Ameriprise Financial
Atlantic Trust
Dimensional Fund Advisors
BlackRock
Arrowstreet Capital, Limited Partnership
Citadel Advisors
Neuberger Berman Group

View all funds holding AstraZeneca